Gossamer Bio
GOSS
Gossamer Bio (GOSS) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Overweight | $4.00 from $15.00 | Aug 14, 2026 |
| Leerink Partners | Upgraded | Market Perform → Outperform | $1.00 | Jul 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $2.00 | Jul 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $2.00 from $5.00 | Jun 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | May 26, 2026 |
| Barclays | Maintained | Underweight | $0.28 from $0.30 | May 19, 2026 |
| Cantor Fitzgerald | Downgraded | Overweight → Neutral | — | Mar 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $10.00 | Mar 6, 2026 |
| Oppenheimer | Maintained | Outperform | $3.00 from $12.00 | Mar 5, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 from $6.00 | Feb 24, 2026 |
| Barclays | Downgraded | Overweight → Underweight | $0.30 from $9.00 | Feb 24, 2026 |
| Wedbush | Downgraded | Outperform → Neutral | $1.00 from $6.00 | Feb 24, 2026 |
| Barclays | Initiated Coverage | Overweight | $9.00 | Jan 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Jan 22, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | — | Sep 11, 2025 |
| UBS | Upgraded | Neutral → Buy | $9.00 from $1.25 | Sep 10, 2025 |
| Wedbush | Maintained | Outperform | $5.00 from $4.00 | Aug 6, 2025 |
| Scotiabank | Initiated Coverage | Sector Outperform | $11.00 | Jul 14, 2025 |
| Wedbush | Maintained | Outperform | $4.00 | May 16, 2025 |
| Goldman Sachs | Maintained | Buy | $8.00 from $7.00 | May 16, 2025 |
Frequently asked questions
What is the latest analyst rating on GOSS?
On Aug 14, 2026, Piper Sandler maintained Gossamer Bio at Overweight with a price target of $4.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.